Arrivent Biopharma, Inc. · NASDAQ:AVBP
Vivo Opportunity, LLC reported a 5.00% stake in Arrivent Biopharma, Inc. (Schedule 13G)
Event Oct 6, 2026 · Filed Oct 13, 2026
Vivo Opportunity, LLC reported a 5.00% stake in Arrivent Biopharma, Inc., 2,472,701 shares, as a passive investor on Oct 6, 2026. Filed Oct 13, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 2,472,701
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 3.10% | 1,514,446 |
| Vivo Opportunity Co-Invest, L.P. | 0.30% | 176,752 |
| Vivo Opportunity Co-Invest (Cycle 3), L.P. | 1.60% | 781,503 |
| Vivo Opportunity, LLC | 5.00% | 2,472,701 |
| Vivo Opportunity Cayman Fund, L.P. | 0.30% | 152,971 |
| Vivo Opportunity Cayman, LLC | 0.30% | 152,971 |
Source
Related
- Arrivent Biopharma, Inc.
- Vivo Opportunity, LLC
- Arrivent Biopharma, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026
- Schedule 13G/A · Hillhouse Investment Management, Ltd. · Feb 17, 2026